Global Health

Openings for Global Health Corporate Champions in Accra Ghana

Employees From Multiple Companies to Form Pro Bono Team With Support From USAID
Press Release

WASHINGTON, D.C., February 3, 2016 /3BL Media/- Global Health Corporate Champions is making pro bono experiences more accessible and affordable for companies interested in exploring pro bono in a critical emerging market.

Sanofi and the Institut Pasteur Reward Four Researchers for Their Major Contributions in the Service of Health

4th Edition of the Sanofi - Institut Pasteur Awards
Press Release

PARIS, November 12, 2015 /3BL Media/ - Sanofi and the Institut Pasteur have attributed today the Sanofi - Institut Pasteur Awards for the fourth year in a row. Four major researchers with international recognition have been rewarded for their works in two major fields for global health: tropical and neglected diseases and immunology.

Global Pro Bono Converts Insight to Innovation

Merck Leverages Service Fellowships to Advance Learning, Employee Engagement & Impact
Article

Over the last ten years, leading companies have begun investing their greatest asset—their human capital—in “giving back” by improving lives around the world through global pro bono programs. Such programs place employees in short-term volunteer assignments within local social-sector organizations for a period of three weeks to three months in emerging or growth markets, from India to Brazil.

Could Cervical Cancer Be the Next Polio?

Innovations in Diagnostics, Treatment, and Monitoring Could Eradicate Cervical Cancer
Article

Augustina Mejiasamata, a 34-year- old Quechua woman who lives in an Andes mountain village two hours outside of Cusco, Peru, had already waited in line for almost an hour to receive her free Pap smear and breast exam.

“Por qué vino Ud. a la clinica hoy?” Why did you come to the clinic today? I asked.

About the Novartis Malaria Initiative

Learn about the disease and what Novartis is doing to contribute to its eradication
Multimedia with summary

Novartis Foundation Leprosy Elimination Dialogue Event Press Release

Novartis Foundation is convening global health experts at a summit in Brazil to discuss the current state of leprosy treatment & care
Press Release

The Novartis Foundation convenes experts to help finish the last mile in leprosy elimination

Sanofi to Receive “Patent for Humanity” Award at White House

U.S. Patent and Trademark Office Honors Sanofi for its Anti-Malarial Treatment
Press Release

BRIDGEWATER, NJ, April 15, 2015 /3BL Media/ – Sanofi announced today that the U.S. Commerce Department’s United States Patent and Trademark Office (USPTO) named the company one of 10 recipients of its prestigious “Patent for Humanity” award. Sanofi is being recognized for its patent that covers an innovative chemical and industrial process for producing semi-synthetic artemisinin utilized in the production of anti-malarial artemisinin-based combination therapies.

New GBCHealth Report Documents Indian Business Action on the Millennium Development Goals

"Business and the Health MDGs in India: Closing the Gaps"
Press Release

March 2, 2015 /3BL Media/ - A new report by GBCHealth, written in partnership with the MDG Health Alliance, presents a snapshot of health-related corporate investments in India, with a focus on business action on the MDGs. Based on survey findings from 23 leading Indian and multinational companies, the report – titled Business and the Health Millennium Development Goals: Closing the Gaps – documents the key characteristics of health CSR programs.

P&G Celebrates 10 years of Providing Clean Drinking Water and Improving Global Health

P&G recognizes its partners at the 2014 Clinton Global Initiative Annual Meeting
Press Release

NEW YORK, September 24, 2014 /3BL Media/ –The Procter & Gamble Company (NYSE:PG) honored the critical role P&G’s partners  have played in the Company’s efforts to provide safe drinking water and help save lives around the world.

BSR Conference 2014 Speaker Video: Sir Andrew Witty, CEO, GlaxoSmithKline

Multimedia with summary

GlaxoSmithKline CEO Sir Andrew Witty spoke at the BSR Conference 2014: Transparency and Transformation, which took place November 4-6 in New York, during a plenary session. Watch the full video now:

Pages

Subscribe to Global Health